298 related articles for article (PubMed ID: 31997800)
1. Toxic tau: structural origins of tau aggregation in Alzheimer's disease.
Mamun AA; Uddin MS; Mathew B; Ashraf GM
Neural Regen Res; 2020 Aug; 15(8):1417-1420. PubMed ID: 31997800
[TBL] [Abstract][Full Text] [Related]
2. Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy.
Ye J; Wan H; Chen S; Liu GP
Neural Regen Res; 2024 Jul; 19(7):1489-1498. PubMed ID: 38051891
[TBL] [Abstract][Full Text] [Related]
3. Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.
Chu D; Yang X; Wang J; Zhou Y; Gu JH; Miao J; Wu F; Liu F
Neural Regen Res; 2024 Jun; 19(6):1221-1232. PubMed ID: 37905868
[TBL] [Abstract][Full Text] [Related]
4. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
6. Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.
Madav Y; Wairkar S; Prabhakar B
Brain Res Bull; 2019 Mar; 146():171-184. PubMed ID: 30634016
[TBL] [Abstract][Full Text] [Related]
7. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
8. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology.
Wischik CM; Harrington CR; Mukaetova-Ladinska EB; Novak M; Edwards PC; McArthur FK
Ciba Found Symp; 1992; 169():268-93; discussion 293-302. PubMed ID: 1490426
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
11. Global Conformation of Tau Protein Mapped by Raman Spectroscopy.
Gorantla NV; Khandelwal P; Poddar P; Chinnathambi S
Methods Mol Biol; 2017; 1523():21-31. PubMed ID: 27975242
[TBL] [Abstract][Full Text] [Related]
12. Tau immunotherapies for Alzheimer's disease.
Hoskin JL; Sabbagh MN; Al-Hasan Y; Decourt B
Expert Opin Investig Drugs; 2019 Jun; 28(6):545-554. PubMed ID: 31094578
[TBL] [Abstract][Full Text] [Related]
13. Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau.
Santa-Maria I; Hernández F; Del Rio J; Moreno FJ; Avila J
Mol Neurodegener; 2007 Sep; 2():17. PubMed ID: 17822548
[TBL] [Abstract][Full Text] [Related]
14. Tau Biology and Tau-Directed Therapies for Alzheimer's Disease.
Bakota L; Brandt R
Drugs; 2016 Mar; 76(3):301-13. PubMed ID: 26729186
[TBL] [Abstract][Full Text] [Related]
15. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
